Burning Rock Biotech Limited (BNR)
NASDAQ: BNR · Real-Time Price · USD
9.32
-0.78 (-7.72%)
At close: May 29, 2026, 4:00 PM EDT
9.95
+0.63 (6.76%)
After-hours: May 29, 2026, 7:08 PM EDT

Burning Rock Biotech Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
9821273952311,002
Market Cap Growth
249.78%191.77%-23.75%-58.75%-76.94%-58.62%
Enterprise Value
35.72147.315.228.89101.66774.6
Last Close Price
9.3220.156.759.3022.5095.30
PS Ratio
1.272.751.031.252.8312.54
PB Ratio
1.282.770.910.881.383.45
P/TBV Ratio
0.160.400.130.120.200.54
EV/Sales Ratio
0.461.910.070.121.259.69
Debt / Equity Ratio
0.050.050.050.000.010.03
Net Debt / Equity Ratio
-0.81-0.81-0.80-0.78-0.74-0.76
Net Debt / EBITDA Ratio
13.1613.161.531.131.001.88
Net Debt / FCF Ratio
12.9212.924.792.281.622.05
Asset Turnover
0.630.630.540.410.290.21
Inventory Turnover
2.462.462.331.751.451.50
Quick Ratio
2.672.672.572.902.574.38
Current Ratio
2.992.992.923.363.064.89
Return on Equity (ROE)
-9.92%-9.92%-51.38%-67.85%-64.67%-37.35%
Return on Assets (ROA)
-6.24%-6.24%-36.50%-50.76%-50.61%-32.22%
Return on Invested Capital (ROIC)
-23.03%-23.03%-129.16%-175.69%-186.40%-181.15%
Return on Capital Employed (ROCE)
-9.20%-9.20%-51.24%-68.55%-63.61%-36.83%
Buyback Yield / Dilution
-3.27%2.26%-5.05%0.20%2.35%-0.31%
Total Shareholder Return
-3.27%2.26%-5.05%0.20%2.35%-0.31%
SEC Filings: 10-K · 10-Q